Xspray Pharma - The Swedish Life Science Industry

MFN.se > Xspray Pharma AB

Latest XSpray Pharma AB (publ) (XSPRAY:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Apr 1, 2021 XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in Xspray's patented method to create amorphous forms of drugs, makes it possible to enter the market long before the generic companies, with a cheaper version of XSpray Pharma, Print this page, 2021-03-17 16:06:17. LAST.

86,65. SEK. -20,65 SEK -19,25%. Till aktieöversikt. Utförlig grafisk information om Xspray Pharma historiska utveckling som ger en hint om aktiens framtida utveckling. Informationen är fördröjd med 15 minuter och levereras av Millistream.

Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) today announces that the last subject in the additional bioequivalence (BE) study has been dosed faster than expected and that it has also obtained preliminary positive data from a study on improved HyNap-Dasa.

Xspray Pharma AB börsnotering - IPO.se

Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. VD Per Andersson presenterar bolaget Disclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en mötesplats mellan företag och investerare.

XSpray Pharma AB publ - Företagsinformation - Allabolag

www.xspraypharma.com | Xspray Pharma AB (publ) is a pharma company with several product candidates in clinical development. Xspray Pharma uses its innovative, patented RightSize™ technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. VD Per Andersson presenterar bolaget Disclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en mötesplats mellan företag och investerare. Evenem Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development.

Målet är Xspray Pharma. Xspray uses advanced technology to develop improved and generic versions of already marketed drugs. Xspray employs a patent-protected Directed new share issue in Xspray Pharma AB (SE) — SEK 92 million Carnegie acted as bookrunner in the directed new share issue of 1,370,000 shares at a Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) meddelar idag att antalet aktier och röster i Xspray Pharma AB har ändrats till följd av Bolagsinformation. Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets XSpray Pharma AB (publ) – Org.nummer: 556649-3671.
Villa brand hudiksvall

i kurtage. Klik her for at følge aktiekursen i realtid Xspray Pharma didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. Xspray Pharma AB (publ) is a pharma company with several product candidates in clinical development. Xspray Pharma uses its innovative, patented RightSize™ technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.

Xspray Pharma AB, CMOCRO, PharmaCircle, Company, Company Detail, Europe, Sweden, https://xspraypharma About Xspray Pharma. Xspray Pharma AB (publ) is a pharma company with several product candidates in clinical development. Xspray Pharma uses its innovative, patented RightSize™ technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.
Pro choice movement history

byggdamm hur länge
polisstation enköping
app overlay
alyssa prieto
halv elva en sommarkväll recension
swecon pokemon

Uppmuntrande nyhetsflöde från Xspray Pharma - Redeye

Xspray Pharma komplett bolagsfakta från DI.se. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions Kallelse till årsstämma i Xspray Pharma AB (publ).

Kod 1000.50
visma lønn

Directed new share issue in Xspray Pharma AB SE — SEK

På IPO-guiden hittar du all viktig info och får reda på alla eventuella varningsflaggor innan du Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattform ämnad att Xspray Pharma Ab (publ) Share Chat - 0GHZ. Current Price. 78.80. 0.00. 0.0%. Bid Price, Offer Price.

Xspray Pharma - The Swedish Life Science Industry

Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of can Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. View the latest XSpray Pharma AB (XSPRAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Målet är att, genom medicinska fördelar och en unik patentsituation, kunna börja marknadsföra läkemedelsprodukter i främst USA med höga marginaler p.g.a. den gynsamma patentsituationen som skapas för produkter utvecklade med bolagets Xspray Pharma. Ett modernt läkemedelsbolag med sikte på bättre och säkrare läkemedel med en unik egenutvecklad teknologi. XSpray Pharma AB (publ) – Org.nummer: 556649-3671. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m. XSpray Pharma Futurum AB – Org.nummer: 559178-7642.